期刊文献+

血清肿瘤标记物对非小细胞肺癌的诊断价值 被引量:4

Diagnostic Value of Single and Combined Determination of Serum TPS Cyfra21-1 and Ferritin in patients with NSCLC
下载PDF
导出
摘要 目的:探讨血清组织多肽特异性抗原(TPS)、细胞角蛋白19片段(Cyfra21-1)和铁蛋白(Ferritin)单项及联合检测对非小细胞肺癌的诊断价值。方法:采用酶联免疫吸附(ELISA)法测定108例NSCLC患者和86例健康人的血清中TPS水平,同时用电化学发光法测定Cyfra21-1和Ferritin水平。结果:肺癌组三项血清肿瘤标记物水平及阳性率均显著高于健康对照组(P<0.01)。TPS诊断肺腺癌的敏感性优于其他两项肿瘤标记物(P<0.05);Cyfra21-1在鳞癌组血清浓度及阳性率明显高于腺癌组(P<0.01)。三项肿瘤标记物单项检测时,TPS的敏感性最高,Cyfra21-1的特异性最高;三项联合检测时的特异性有所降低,但敏感性和准确率显著提高(P<0.01)。结论:TPS、Cyfra21-1和Ferritin单项及联合检测对NSCLC的诊断及病理学类型的鉴别有较高的临床价值。 Objective: To investigate the diagnostic value of single and combined determination of serum tissue polypeptide specific antigen(TPS),cytokeratin 19 fragment(Cyfra21-1) and ferritin in patients with non-small cell lung cancer(NSCLC).Method: The levels of serum TPS were detected in 108 patients with NSCLC and 86 cases of healthy adults by enzyme-linked immunosorbent assay(ELASA),and the levels of Cyfra21-1 and ferritin were detected by electrochemiluminescence.Result: The serum levels and positive rates of the three tumor markers in lung cancer group were significantly higher than those in healthy adults(P0.01).TPS showed higher sensitivity than the other two tumor markers in the diagnosis of pulmonary adenocarcinoma(P0.05);The serum levels and positive rates of Cyfra21-1 in squamous carcinoma group were significantly higher than those in adenocarcinoma group(P0.01).TPS showed the highest sensitivity and Cyfra21-1 showed the highest sensitivity in single tumor marker detection;Their combined detection could reduce the specificity to a certain extent,but could significantly improve the sensitivity and the accuracy(P0.01).Conclusion: The single and combined detection TPS,cyfra21-1 and ferritin has high clinical value in the diagnosis of NSCLC and the differentiation of pathology types.
出处 《河北医学》 CAS 2012年第3期297-300,共4页 Hebei Medicine
关键词 非小细胞肺癌 肿瘤标记物 组织多肽特异性抗原 细胞角蛋白19片段 Non-small cell lung cancer Tumor marker Tissue polypeptide specific antigen Cytokeratin 19 fragment
  • 相关文献

参考文献11

  • 1Bjorklund B,Einarsson R.TPS in oncologic practice:a re-view with reference to 3000 cases of lung cancer[J].TumorDiag Ther,1996,17(1):67-72.
  • 2Tu DG,Wang ST,Chang TT,et al.The value of serum tissuepolypeptide specific antigen in the diagnosis of hepatocelluarcarcinoma[J].Cancer,1999,20(1):147-152.
  • 3高洪波,巩平,李娜.组织多肽特异性抗原(TPS)临床研究进展[J].现代肿瘤医学,2010,18(3):602-605. 被引量:12
  • 4Niman B,Amir G,Lafair J,et al.Prognostic value of CYFRA21-1,TPS and CEA in different histologic types of non-small cell lung cancer[J].Anticancer Res,1999,19(4C):3549-3552.
  • 5孟凡亮,胡杰贵,李自生.血清TPS,CEA,CYF RA2 1-1,NSE联合检测对肺癌的诊断价值[J].临床肺科杂志,2011,16(2):223-225. 被引量:12
  • 6Pujol J L,Boher J M,Grenier J.CYFEA21-1,Neuron specif-ic enolase and prognoses of non-small cell lung cancer:pro-spective study in 621 patients[J].Lung Cancer,2001,21(2-3):221.
  • 7Ando S,Kimura H,Lwai N,et al.Optimal combination ofseven tumor markers in prediction of advanced stage at firstexamination of patients with non-small cell lung cancer[J].Anticancer Res,2001,21(4B):3085-3092.
  • 8Ando S,Suzuki M,Yamamoto N,et al.The prognostic valueof both neuron-specific enolase(NSE)and Cyfra21-1 insmall cell lung cancer[J].Anticancer Res,2004,24(3B):1941-1946.
  • 9Ardizzoni A,Cafferata M A,Tiseo M,et al.Decline in serumcarcinoembryonic antigen and cytokeratin 19 fragment duringchemotherapy predicts objective respone and survival in pa-tients with advanced nonsmall cell lung cancer[J].Cancer,2006,107(12):2842-2849.
  • 10李立青,董振南,田亚平.血清铁蛋白及其他四种肿瘤标志物检测对肺癌的诊断价值[J].标记免疫分析与临床,2009,16(2):68-70. 被引量:36

二级参考文献22

共引文献64

同被引文献70

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部